Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo

A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma

(2016) Tong Wang et al.   CANCER LETTERS

RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models

(2016) P. Strop et al.   MOLECULAR CANCER THERAPEUTICS

Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma

(2016) Supritha G. Swamy et al.   Targeted Oncology

Antibody-drug conjugates for cancer therapy: The technological and regulatory challenges of developing drug-biologic hybrids

(2015) Gregory S. Hamilton   BIOLOGICALS

Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics

(2015) Eunhee G. Kim et al.   Biomolecules & Therapeutics

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

New insights into molecular diagnostic pathology of primary liver cancer: Advances and challenges

(2015) Wen-Ming Cong et al.   CANCER LETTERS

Doxorubicin-Mediated Cardiotoxicity: Role of Mitochondrial Connexin 43

(2015) Michela Pecoraro et al.   Cardiovascular Toxicology

Systemic Therapy of Hepatocellular Carcinoma

(2015) Aparna Kalyan et al.   Clinics in Liver Disease

A novel antibody targeting CD24 and hepatocellular carcinoma in vivo by near-infrared fluorescence imaging

(2015) Hua He et al.   IMMUNOBIOLOGY

Downregulation of STAT3 phosphorylation enhances tumoricidal effect of IL-15-activated dendritic cell against doxorubicin-resistant lymphoma and leukemia via TNF-α

(2015) Sumit Kumar Hira et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells

(2015) Ji Na Kong et al.   INTERNATIONAL JOURNAL OF CANCER

Small Sized EGFR1 and HER2 Specific Bifunctional Antibody for Targeted Cancer Therapy

(2015) Li Ding et al.   Theranostics

Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy

(2014) Ravi V. J. Chari et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

CD24 single nucleotide polymorphisms and cancer risk

(2014) Shushan Yan et al.   TUMOR BIOLOGY

Novel Conjugation of Tumor-Necrosis-Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Monomethyl Auristatin E for Efficient Antitumor Drug Delivery

(2013) Li-Qiang Pan et al.   ADVANCED MATERIALS

A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology

(2013) Scott C. Jeffrey et al.   BIOCONJUGATE CHEMISTRY

Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas

(2013) A V Salnikov et al.   BRITISH JOURNAL OF CANCER

Targeted Cancer Therapy with a 2-Deoxyglucose-Based Adriamycin Complex

(2013) J. Cao et al.   CANCER RESEARCH

Site-specific antibody drug conjugates for cancer therapy

(2013) Siler Panowski et al.   mAbs

CD24 controls Src/STAT3 activity in human tumors

(2012) Niko P. Bretz et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Direct Measurements on CD24-Mediated Rolling of Human Breast Cancer MCF-7 Cells on E-Selectin

(2011) Ja Hye Myung et al.   ANALYTICAL CHEMISTRY

CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation

(2011) Terence Kin Wah Lee et al.   Cell Stem Cell

The CD24 Protein Inducible Expression System Is an Ideal Tool to Explore the Potential of CD24 as an Oncogene and a Target for Immunotherapyin Vitroandin Vivo

(2011) Shiran Shapira et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Bright and stable near-infrared fluorescent protein for in vivo imaging

(2011) Grigory S Filonov et al.   NATURE BIOTECHNOLOGY

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

(2010) J.-L. Raoul et al.   CANCER TREATMENT REVIEWS

Antibody−Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies

(2009) Laurent Ducry et al.   BIOCONJUGATE CHEMISTRY

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

(2009) Johannes Lammer et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery

(2009) X.-R. Yang et al.   CLINICAL CANCER RESEARCH

Near-infrared fluorescence: application to in vivo molecular imaging

(2009) Scott A Hilderbrand et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

CD24 Expression Is a Novel Prognostic Factor in Esophageal Squamous Cell Carcinoma

(2008) Akihiko Sano et al.   ANNALS OF SURGICAL ONCOLOGY